Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Valmet to supply anti-surge and load-sharing control for Nyagangazpererabotka's gas compressing process in Western Siberia

Valmet Oyj's trade press release on January 4, 2018 at 11:00 a.m. EET Valmet will supply anti-surge and load-sharing control for Nyagangazpererabotka's gas compressing process in Nyagan, Western Siberia, Russia. Accurate and efficient solutions will enable the plant to save electricity in gas compression. The order was included in Valmet's third quarter 2017 orders received. The new control solution will be started up in July 2018. "We have worked with Valmet since 2005 when we acquired the first control system for our plant. We know Valmet DNA is a very reliable solution," says

Camanio Care AB (publ) is participating in an International Network meeting together with SKL

In the end of May 2018, Camanio Care is specially invited to join SKL, Tibro Municipality and Halmstad University on an international leadership networking meeting within disabilities and mental illness at the Globen Annexet in Stockholm, Sweden.The international leadership network is called IIDL (International Initiative for Disability Leadership). It is a unique network for innovation, knowledge development and methodology to support the vision of full participation in society for people with disabilities. The exchange takes place between countries, governments and organizations. The

Nokian Tyres introduces new state-of-the-art products for its winter tyre range

Press release 4 January 2018 Nokian Tyres introduces new state-of-the-art products for its winter tyre range: Nokian Hakkapeliitta R3, Nokian Hakkapeliitta R3 SUV, Nokian WR SUV 4 and Nokian WR G4  The versatile, high-quality winter tyre range of the world’s northernmost tyre manufacturer is complemented as Nokian Tyres  introduces four new product families: Nordic non-studded Nokian Hakkapeliitta R3 and R3 SUV winter tyres for the Nordic, Russian and North American, Nokian WR SUV 4 for the Central European and Nokian WR G4 for the North American markets.

Leading infrastructure wholesale company selects IFS Applications 9 to support future growth

ERP solution from IFS provides Melbye Skandinavia with a unified solution, creating a more effective and transparent supply chain IFS , the global enterprise applications company, today announces that Melbye Skandinavia, a leading Scandinavian wholesale company of infrastructure solutions within Energy & Telecom, has selected IFS Applications ™ 9 to increase efficiency and support future growth. Addovation, a member of the IFS Partner Network, has sold the solution and will implement it. The

Frida Rosenholm appointed General Counsel of Securitas

Frida Rosenholm has been appointed Senior Vice President General Counsel of Securitas. She succeeds Henrik Zetterberg, who has been appointed COO for the division Security Services Europe with focus on Northern Europe, as previously announced.Since October 2012, Frida Rosenholm has been General Counsel of the EF Education First Group. Before joining EF, she held several senior positions with the listed companies Pergo AB and Pleiderer AG. Prior to this, she was an associate at Mannheimer Swartling Advokatbyrå. Frida Rosenholm has a Master of Laws Degree from Stockholm University. Frida

Corral Petroleum Holdings to attend the SEB Nordic Seminar on January 10, 2018 in Copenhagen

Corral Petroleum Holdings will attend the SEB Nordic Seminar on January 10, 2018 at the Bella Sky Hotel in Copenhagen, Denmark.Petter Holland, CEO, and Gunilla Spongh, CFO, are scheduled to present at the SEB Nordic Seminar. The presentation is scheduled for Wednesday, January 10, 2018 at 11.00 a.m (CET). For further information, please contact:Amelie Wilson                                                            Investor Relations Manager                                          Tel: + 46 (0)10-450 10 21                                                 Email: amelie.wilson@

Greensmith Energy will help reduce greenhouse gas emissions in the Azores

Wärtsilä Corporation, Press release, 4 January 2017 at 10.00 a.m. EETGreensmith Energy, a part of the technology group Wärtsilä, will deliver an integrated energy management system based on its industry-leading Greensmith Energy Management System (GEMS) software for Graciolica Lda’s microgrid power facility in the Azores. When completed, Graciosa Hybrid Renewable Power Plant will enable 1 MW of solar and 4.5 MW of wind power to be supplied to the local electricity grid, reducing the islands’ reliance on imported fossil fuels and significantly reducing greenhouse gas (GHG) emissions. The

BIMobject AB: BIMobject signs cooperation agreement with PIM-system provider inRiver

A cooperation agreement has been signed between BIMobject and global PIM-system provider inRiver. The cooperation will make it easier for building product manufacturers to transform their product information in PIM to specification data for BIM, which gives significant marketing possibilities. The direct integration into the platform BIMobject® Cloud will automatise manual processes and lead to faster digitalisation. The agreement entails no noteworthy costs for either party. BIMobject and the market-leading corporation inRiver have entered into a cooperation agreement in order to enable

Leading Nordic bitcoin broker Prasos breaks records raising €2.5M

PRESS RELEASE Helsinki, 4 January 2018 – Prasos raised €2.5m in equity funding to boost its expansion in Europe and to develop cryptocurrency based investment services for traditional investors.The equity offering was launched on the Invesdor platform on November 9th and the company reached the first million at the beginning of December. The investment pace kept growing and the last million of the 2.5 million euro cap was invested during only six days as fear of missing out started to speed up investments. Finally the round was closed on 23rd of December - 12 days before the official

Isofol to present at the 10th Annual Biotech Showcase Conference

Isofol Medical AB (publ), a clinical oncology company, announces that Chief Executive Officer Anders Rabbe and Chief Commercial Officer Sven Erickson will present at the 10th Annual Biotech Showcase Conference, to be held during the 8-10th of January in San Francisco, USA. The event is a networking conference dedicated to providing biotechnology companies with an opportunity to meet with, investors and pharmaceutical executives, during the course of the largest annual healthcare investor conference, the 36th Annual J.P. Morgan Healthcare Conference. Sven Erickson, CCO of Isofol Medical,

Invitation to a presentation of the Momentum Group's Interim Report for the third quarter 2017/18

Momentum Group will publish its Interim Report for the third quarter of the financial year 2017/18 on Friday, 9 February 2018 at 08:00 a.m. CET. In conjunction with this, Momentum Group are pleased to issue this invitation to a webcast conference call in which CEO & President Ulf Lilius and CFO Niklas Enmark will present the report and answer any subsequent questions. The conference call and presentation are available on the web or by telephone in accordance with the details below. Questions may be asked both at the conference call and via the webcast. DATE:                     Friday,

Preliminary revenue October-December 2017

Based on the information available for the period October-December 2017, G5 forecasts quarterly revenue of approximately SEK 356 M, which corresponds to achieving 93 per cent revenue growth compared to the same period of 2016. For the full year 2017, G5 forecasts revenue of approximately SEK 1,135 M, which corresponds to achieving 120 per cent revenue growth compared to 2016. Vlad Suglobov, CEO, comments: “The fourth quarter, with its seasonal characteristics, has presented new opportunities to scale our user base and revenue. Like one year ago in Q4’16, we went ahead and increased our

Konecranes Plc: Notice pursuant to the Finnish Securities Market Act, Chapter 9, Section 10

KONECRANES PLC STOCK EXCHANGE RELEASE January 4, 2018  09.00 EETKonecranes Plc: Notice pursuant to the Finnish Securities Market Act, Chapter 9, Section 10Konecranes has on January 3, 2018, received a notification under Chapter 9, Section 5 of the Securities Market Act, according to which the total holding of BlackRock, Inc. in Konecranes Plc’s shares and votes has risen above 15 percent.On January 2, 2018, Blackrock Inc.’s total holding through shares and financials instruments amounted to 15.00 percent of Konecranes Plc’s shares and votes.Total positions of BlackRock, Inc.:

Peab builds apartments in Esbo, Finland

Peab has been commissioned to build 135 apartmentsin Esbo.  The customer is Kojamo GroupLumo-Kodit Oy, Finland’s largest private landlord.The contract is worth around EUR 14 million. Construction will commence in January 2018 and the apartments will be ready to move into in November 2019. The project was order registered in the fourth quarter of 2017.For further information, please contact:Mika Katajisto, CEO Peab Oy, cell: +358 40 570 1025Henrik Samuelson, temp Press Officer, cell: +46 725 33 45 85

Completed enrollment in Hansa Medical’s international multi-center Phase II study Highdes

Hansa Medical AB (Nasdaq Stockholm: HMED), a biopharmaceutical company focusing on novel immunomodulatory enzymes, announced today the completion of enrollment for the international multi-center study Highdes.The study aimed to recruit 15-20 patients. A total of 18 patients have been treated with the company’s lead candidate IdeS and subsequently transplanted at five clinics in the US and Europe. All treated and transplanted patients will be followed up for six months. The primary objective of the study - to turn a positive cross-match test into a negative and thereby enable kidney

Bravida grows in Finland – acquires Adison Oy

Bravida acquires Finnish Adison Oy and strengthens its position as a multi-technical service provider in the fast-growing Helsinki region. The acquired company has about 70 employees and a turnover of approximately SEK 190 million.Adison Oy is a major supplier within replumbing and offers services in electricity, HVAC, ventilation and building construction. With the acquisition, Bravida achieves a stronger market presence in the important metropolitan area. – This is a strategic acquisition for Bravida. Our goal is to grow in Finland, and with this acquisition we become one of the major

MEDICOVER ACCELERATES INVESTMENTS IN INDIA

Medicover has increased its investments in the Indian hospital chain MaxCure ahead of previous discussed timetables. The initial ownership of 22% has been increased to 26.8% through an injection of new capital of EUR 2.6 million. The ownership is expected to be increased shortly to 37.2% via a secondary share purchase of EUR 3.4 million and an adjustment of share capital structure. This investment brings the total cost of current ownership in Maxcure to EUR 16.6 million. MaxCure will use the additional funds to expand existing hospital sites, acquire a minority in an existing subsidiary

Veidekke sold residential units at a value of NOK 5.7 billion in 2017

Veidekke sold 1,215 residential units in 2017, of which 210 were sold in Q4. The number of units in production was 3,173 and the sales ratio was 83% at year-end. Overall, Veidekke sold residential units at a value of NOK 5.7 billion in 2017 Veidekke sold 210 residential units in Q4 2017, which is on a par with Q3. The number of units in production increased somewhat compared to year-end 2016, and there were 3,173 units in production at year-end 2017, of which Veidekke's share was 2,505. The sales ratio for units in production was 83%. "Residential sales are on a par with Q3, but

Targovax announces that ONCOS-102 generates immune activation in checkpoint inhibitor refractory melanoma patients

Oslo, Norway, 4 January 2018 - Targovax ASA (OSE: TRVX), a clinical stage company focused on developing immuno-oncology therapies to target solid tumors, today announces immune activation data in the first four patients treated with ONCOS-102 followed by the checkpoint inhibitor (CPI) pembrolizumab (KEYTRUDA®) in patients with advanced melanoma whose disease has progressed after prior CPI treatment. This is the first time ONCOS-102 has been used therapeutically in melanoma patients, and also the first time the virus has been administered to CPI refractory patients. In this Phase I open

Elo renews infrastructure and cloud services agreement with Tieto

The Finnish mutual pension insurance company Elo and Tieto have entered into an agreement for the prolongation of the existing contract. This will be focused on cost efficiency and scalability for Elo, as well as a common transformation program, setting Elo up for future success.Under the five-year agreement, Tieto will provide Elo with infrastructure and cloud services, and create a scalable modern platform to help increase cost-efficiency and simplification as well as creating favourable conditions for Elo’s future business needs and an efficient value chain. The partnership will focus

Ambea acquires staffing business with school focus

Ambea acquires Elevhälsan from PR-vård group.  Elevhälsan focus on staffing solutions for primary and secondary school. Elevhälsan complement Ambeas existing staffing solutions and will be a part of Rent a Doctor and Nurse.Elevhälsan started in 2005 and offers staffing solutions and comprehensive solutions for care provider responsibility (vårdgivaransvar). Elevhälsan offers school nurses, school doctors, counselors and psychologists. Elevhälsan is represented all over Sweden with a strong position in Stockholm, Uppsala and Östergötland. Revenue for 2016 was approx. SEK 22 million. For

Not a Single Story – A Collaboration between NIROX Foundation, South Africa and The Wanås Foundation, Sweden

From 12 May 2018 until the end of July, NIROX Foundation in South Africa will host Not a Single Story – The Winter Sculpture Exhibition, co-curated by Elisabeth Millqvist and Mattias Givell, the leadership duo behind the Swedish sculpture park The Wanås Foundation – Wanås Konst. The exhibition is an exchange between sculpture parks on two continents looking at individual artistic practices as overlapping dialogues and bring forward contemporary concerns and working methods related to sculpture. When we realize that there is never a single story about any place we regain a kind of paradise.

Changes in Enviro’s Election Committee

N.B. The English text is an in-house translation of the original Swedish text. Should there be any disparities between the Swedish and the English text, the Swedish text shall prevail. The Election Committee of Scandinavian Enviro Systems AB has changed with the appointment of Stefan Persson, representing Mardal Invest AB.Enviro’s Election Committee as per January 1st, 2018: · Stefan Winström (chairman, appointed by KL Ventures II AB) · Lennart Persson (shareholder) · Stefan Persson (appointed by Mardal Invest AB) · Stig-Arne Blom (Chairman of the Board, Enviro) The

Panion’s epilepsy product candidate for gene therapy in the dog: FDA has established an Investigational New Animal Drug (INAD) file.

Panion Animal Health AB (“Panion”) has in Q4-17 requested the FDA to open an Investigational New Animal Drug application file to carry out the development of our new product for use in the dog. Panion plans to develop and gain approval for the use of CG-01-canine, a recombinant adeno-associated virus vector expressing neuropeptide Y and receptor peptide Y2 to treat drug refractory idiopathic epilepsy in the dog via intracranial injection. A summary of the scientific rationale for the therapy and the preliminary work completed to date was submitted and the FDA accepted this with a

There are no items matching the current filter
There are no more items matching the current filter
Back to top